Pubblicazioni

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer

2022 - DIAGNOSTICS

Pacilio, Massimiliano; Conte, Miriam; Frantellizzi, Viviana; De Feo, Maria Silvia; Pisani, Antonio Rosario; Marongiu, Andrea; Nuvoli, Susanna; Rubini, Giuseppe; Spanu, Angela; De Vincentis, Giuseppe

Association between hashimoto thyroiditis and differentiated thyroid cancer: A single-center experience

2022 - FRONTIERS IN ONCOLOGY

Cappellacci, F.; Canu, G. L.; Lai, M. L.; Lori, E.; Biancu, M.; Boi, F.; Medas, F.

Prevalence of Thyroid Nodules and Thyroid Cancer in Individuals with a First-Degree Family History of Non-Medullary Thyroid Cancer: A Cross-Sectional Study Based on Sonographic Screening

2022 - THYROID

Grani, Giorgio; Lamartina, Livia; Montesano, Teresa; Giacomelli, Laura; Biffoni, Marco; Trulli, Fabiana; Filetti, Sebastiano; Durante, Cosimo

Seeking optimization of LT4 treatment in patients with differentiated thyroid cancer

2022 - HORMONES

Stramazzo, I.; Capriello, S.; Antonelli, A.; Fallahi, P.; Centanni, M.; Virili, C.

Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit

2022 - THE ONCOLOGIST

Wirth, Lori J; Durante, Cosimo; Topliss, Duncan J; Winquist, Eric; Robenshtok, Eyal; Iwasaki, Hiroyuki; Luster, Markus; Elisei, Rossella; Leboulleux, Sophie; Tahara, Makoto